153 related articles for article (PubMed ID: 10580184)
21. The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
Haverkate F; Thompson SG; van de Loo JC
Ann Epidemiol; 1992 Jul; 2(4):521-4. PubMed ID: 1342302
[TBL] [Abstract][Full Text] [Related]
22. Plasma fibrinogen in unstable coronary artery disease.
Swahn E; von Schenck H; Wallentin L
Scand J Clin Lab Invest; 1989 Feb; 49(1):49-54. PubMed ID: 2727617
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of patients with stable angina pectoris on antianginal drug therapy.
Hjemdahl P; Eriksson SV; Held C; Rehnqvist N
Am J Cardiol; 1996 Jun; 77(16):6D-15D. PubMed ID: 8677897
[TBL] [Abstract][Full Text] [Related]
24. Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction.
Wallén NH; Held C; Rehnqvist N; Hjemdahl P
Eur Heart J; 1999 Jul; 20(14):1039-43. PubMed ID: 10381855
[TBL] [Abstract][Full Text] [Related]
25. Primary prevention in patients with coronary heart disease: the APSIS study.
Rehnqvist N; Hjemdahl P; Björkander I; Eriksson SV; Forslund L; Held C; Wallén H; Billing E
Cardiovasc Drugs Ther; 1995 Aug; 9 Suppl 3():493. PubMed ID: 8562465
[TBL] [Abstract][Full Text] [Related]
26. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.
Wannamethee SG; Whincup PH; Shaper AG; Rumley A; Lennon L; Lowe GD
J Thromb Haemost; 2009 Oct; 7(10):1605-11. PubMed ID: 19682232
[TBL] [Abstract][Full Text] [Related]
27. Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm.
Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén HN
Cardiologia; 1995 Dec; 40(12 Suppl 1):301. PubMed ID: 8903053
[No Abstract] [Full Text] [Related]
28. Cardiovascular risk factors for stable angina pectoris versus unheralded myocardial infarction.
Dunder K; Lind L; Lagerqvist B; Zethelius B; Vessby B; Lithell H
Am Heart J; 2004 Mar; 147(3):502-8. PubMed ID: 14999201
[TBL] [Abstract][Full Text] [Related]
29. Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris.
Thompson SG; Fechtrup C; Squire E; Heyse U; Breithardt G; van de Loo JC; Kienast J
Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):357-62. PubMed ID: 8630659
[TBL] [Abstract][Full Text] [Related]
30. The pre-existence of an acute coronary event predicts differences in biological parameters and clinical evolution among patients with longstanding stable angina.
Sposito AC; Lemos PA; Maranhão RC; Mansur AP; Cesar LA; Ramires JA
Int J Cardiol; 2003 Oct; 91(2-3):193-200. PubMed ID: 14559130
[TBL] [Abstract][Full Text] [Related]
31. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study.
Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N
J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899
[TBL] [Abstract][Full Text] [Related]
32. Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris.
Umemoto S; Suzuki N; Fujii K; Fujii A; Fujii T; Iwami T; Ogawa H; Matsuzaki M
Am J Cardiol; 2000 Mar; 85(6):715-9. PubMed ID: 12000045
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of angina pectoris experienced during the first month following acute myocardial infarction.
Jespersen CM
Clin Cardiol; 1997 Jul; 20(7):623-6. PubMed ID: 9220178
[TBL] [Abstract][Full Text] [Related]
34. Comparison of metoprolol and verapamil in the treatment of angina pectoris.
Arnman K; Rydén L
Am J Cardiol; 1982 Mar; 49(4):821-7. PubMed ID: 6801951
[TBL] [Abstract][Full Text] [Related]
35. [Unstable stenocardia: indicators of platelet activity and the effect of verapamil].
Gratsianskiĭ NA; Chikvashvili DI; Masenko VP
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):33-9. PubMed ID: 2962587
[TBL] [Abstract][Full Text] [Related]
36. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of post-infarction angina pectoris and the effect of verapamil on the incidence of angina pectoris and prognosis. The Danish Study Group on Verapamil in Myocardial Infarction.
Jespersen CM; Hansen JF; Mortensen LS
Eur Heart J; 1994 Feb; 15(2):270-6. PubMed ID: 8005130
[TBL] [Abstract][Full Text] [Related]
38. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study.
Sinning JM; Bickel C; Messow CM; Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Lackner KJ; Tiret L; Münzel T; Blankenberg S;
Eur Heart J; 2006 Dec; 27(24):2962-8. PubMed ID: 17132649
[TBL] [Abstract][Full Text] [Related]
39. Age and gender differences in left ventricular function among patients with stable angina and a matched control group. A report from the Angina Prognosis Study in Stockholm.
Eriksson SV; Björkander I; Held C; Hjemdahl P; Forslund L; Rehnqvist N
Cardiology; 1996; 87(4):287-93. PubMed ID: 8793161
[TBL] [Abstract][Full Text] [Related]
40. Antianginal efficacy of the combination of felodipine-metoprolol 10/100 mg compared with each drug alone in patients with stable effort-induced angina pectoris: a multicenter parallel group study. The TRAFFIC Study Group.
Emanuelsson H; Egstrup K; Nikus K; Ellström J; Glud T; Pater C; Scheibel M; Tisell A; Tötterman KJ; Forsby M
Am Heart J; 1999 May; 137(5):854-62. PubMed ID: 10220634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
